To be global leaders discovering what causes diseases, how to slow, cure and prevent. We host scientists who see beyond prevailing dogma, who have novel but unproven hypotheses and who have an insatiable appetite to explore what others haven’t.
We are seamless, studying genes-to-populations, supporting student-scientists-to-professors, integrating patient consumers-with-doctors and hosting volunteers-to-technology specialists. A shared-responsibility model to improve the lives of Australians living with disease, sooner.
We host state-of-the-art technology platforms in contemporary certified PC2 facilities, home to ~300 scientists.
Our focus areas
Our research encompasses four focus areas, or areas of strength, including vascular and metabolic disorders, inflammation, infectious disease and wounds, neurodegenerative disorders and cancer.
Vascular and Metabolic Disorders
We are identifying new treatments for blood vessel disorders and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
Inflammation, Infectious Disease and Wounds
We are developing ways to stop the decline in immune system function with ageing, using the immune system to treat arthritis and adult cancers.
Neurodegenerative and Pain
We are exploring new approaches for preventing and treating Alzheimer’s disease, where we’re hoping to slow cognitive decline significantly.
We’re researching interventions for age-associated cancers, focusing on how the immune system influences cancer risk and disease progression.
CHIRI in the news
A ground-breaking Curtin-led research project that discovered a possible cause of Alzheimer’s disease has been crowned the overall winner at the 2022 Curtinnovation Awards.
CHIRI researchers will test a new nano-gel they have created to protect children receiving chemotherapy treatment from the common side effect of hearing loss.
Research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death.
Our researchers have been awarded more than $1.1million from MSWA to conduct vital neurological research, focussing on major outcomes for people living with MS and Alzheimer’s disease.
Connect with us to explore the many ways you can support us and our researchers to make a difference.